SERPINA1 and non-small cell lung carcinoma: Furthermore, other studies have shown that in non-small-cell lung cancer (NSCLC), an increase in the serum concentration of α1-AT is a marker of poor prognosis [59], which could be associated with more aggressive stages and clinical signs of the disease.